US Stock MarketDetailed Quotes

PROF Profound Medical

Watchlist
  • 7.150
  • +0.100+1.42%
Close Dec 27 16:00 ET
  • 7.150
  • 0.0000.00%
Post 16:28 ET
214.70MMarket Cap-5.34P/E (TTM)

Profound Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Profound Medical Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.07M
2.83M
-233.94K
Miss Est.
+74.62%
+63.89%
-7.63%
EPS
-0.30
-0.38
-0.08
Miss Est.
-16.35%
-46.15%
-25.66%
Analyst Rating
Strong Buy

Dec 11, 2024

Profound Medical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.495M--
--2024/Q4-- / 6.038M--
Nov 7, 20242024/Q33.929M / 4.146M--
Aug 8, 20242024/Q22.007M / 3.297M--
May 9, 20242024/Q12.614M / 3.395M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.495M--
--2024/Q4-- / 6.038M--
Nov 7, 20242024/Q33.929M / 4.146M--
Aug 8, 20242024/Q22.007M / 3.297M--
May 9, 20242024/Q12.614M / 3.395M--

Unlock Free Earnings Estimates

Profound Medical Earnings Reports

  • Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 6 17:25 ET

  • Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 7 16:23 ET

  • Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 17 16:47 ET

  • Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 8 16:55 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data